GRIA2 antibody (AA 151-250)
Quick Overview for GRIA2 antibody (AA 151-250) (ABIN734588)
Target
See all GRIA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 151-250
-
Purpose
- GLUR2 Polyclonal Antibody
-
Cross-Reactivity
- Human, Mouse, Rat
-
Predicted Reactivity
- Dog
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human GLUR2
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000),
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- GRIA2 (Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2))
-
Alternative Name
- GLUR2
-
Background
-
Synonyms: GLUR2, GLURB, GluA2, HBGR2, GluR-K2, Glutamate receptor 2, GluR-2, AMPA-selective glutamate receptor 2, GluR-B, Glutamate receptor ionotropic, AMPA 2, GRIA2
Background: Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.
-
Gene ID
- 2891
-
UniProt
- P42262
-
Pathways
- PI3K-Akt Signaling
Target
-